FIGO staging in vulval and endometrial cancer

Key content• FIGO staging for vulval and endometrial cancer was last amended in May 2009 and is now based on surgical pathology. • Staging should be of benefit without significantly increasing morbidity. • Other factors such as tumour type and grade and any comorbidities also contribute to survival.Learning objectives• To understand the principles of cancer staging. • To be aware of the appropriate preoperative preparation. • To be able to stage vulval and endometrial cancer once the histopathology is available.Ethical issues• Surgery should be of benefit regarding survival or in guiding appropriate treatment.Please cite this article as: Edey K, Murdoch J. FIGO staging in vulval and endometrial cancer. The Obstetrician & Gynaecologist 2010;12:245–249.